Skip to content
Screener

Reported November 13, 2025 · Before market open

EPS-$0.59Beat by $0.24
EPS estimate-$0.83

Next report

Date not yet announced

FAQ

When did Tvardi Therapeutics report Q3 2025 earnings?
Tvardi Therapeutics (TVRD) reported Q3 2025 earnings on November 13, 2025 before market open.
What were Tvardi Therapeutics's Q3 2025 revenue and EPS?
Tvardi Therapeutics reported eps of $-0.59 for Q3 2025.
Did Tvardi Therapeutics beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.83 by $0.24.
Where can I find Tvardi Therapeutics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-111310) and the 10-Q periodic report (0001104659-25-111289) directly on SEC EDGAR. The filing index links above go to sec.gov.